The Jehovah's Witnesses have recently updated their medical policies regarding blood use, easing a longstanding prohibition on the use of donated blood. This change, announced on a Friday in 2023, allows members to receive medical products derived from blood while still maintaining a ban on whole blood transfusions. This shift marks the second revision to their blood policy within the same year, reflecting ongoing debates within the organization regarding their stance on medical treatments.
The new regulations clarify that members may accept medical treatments that utilize the four primary components of whole blood: plasma, platelets, red blood cells, and white blood cells. Geoffrey W. Jackson, a member of the organization's Governing Body, emphasized that each individual Christian must make personal decisions about the use of these components in their medical and surgical care.
In addition to these changes, the revised policy empowers members to choose whether or not to donate blood for the production of medical products used in treatments for others, while still prohibiting whole blood transfusions and donations for transfusion purposes.
This update follows an earlier policy change in March 2023, which allowed members to store their own blood for future medical treatment, but not for use by others. Critics of the organization have long challenged its stance on blood transfusions, arguing that the prohibition on a life-saving treatment has led to unnecessary deaths. Former members of the church have voiced their concerns that the teaching has prevented individuals from receiving essential medical care during emergencies, surgeries, or due to injuries.
The Jehovah's Witnesses' reluctance to accept blood transfusions is rooted in their interpretation of certain Bible passages that advocate for "abstaining" from blood. This perspective distinguishes them from other religious traditions, such as Jewish and other Christian denominations, which typically view these passages as pertaining specifically to dietary laws. For the Jehovah's Witnesses, this belief extends to the prohibition of blood transfusions altogether.
Various components of blood play crucial roles in treating different medical conditions. For instance, plasma is commonly utilized for patients suffering from trauma or specific diseases, while red blood cells are often used to treat anemia. White blood cells can help address certain infections, and platelets are pivotal in cancer treatments and other medical interventions.
Jehovah's Witnesses are encouraged to deliberate carefully on the matter of using blood products. Paul Gillies, the international spokesperson for the organization, highlighted the need for individuals to pray, study scripture, and reflect on their beliefs before making decisions regarding their medical treatment. He noted that blood represents life in biblical terms, and thus, it is critical for members to consider this representation in their decision-making processes, ultimately arriving at a decision that aligns with their personal beliefs and relationship with God.
Originating in 19th century America, Jehovah's Witnesses share various beliefs with mainstream Christianity, but they diverge on key theological issues, such as their interpretations of Jesus's nature and biblical prophecies. The organization maintains a distinct viewpoint regarding blood transfusions that sets them apart from most other religious groups. As of 2025, the Jehovah's Witnesses claimed a membership of approximately 1.3 million in the United States and 9.2 million worldwide across more than 200 countries and territories.
In summary, the Jehovah's Witnesses' updated policies reflect a significant shift in their approach to medical treatments involving blood products, underlining the individualistic nature of their faith while navigating the delicate balance between religious convictions and medical needs.
